Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety
Titel:
Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety
Auteur:
Luo, H.Y. Li, Y.H. Wang, W. Wang, Z.Q. Yuan, X. Ma, D. Wang, F.H. Zhang, D.S. Lin, D.R. Lin, Y.C. Jia, J. Hu, X.H. Peng, J.W. Xu, R.H.